Dialysis Billing Pitfalls That Are Draining Revenue

Free Demo

Most dialysis facilities are losing money every single month. Not because of bad clinical care. Not because of staffing issues. Because of billing errors that nobody is catching.

Dialysis billing is one of the most complex billing environments in all of healthcare. You have a bundled payment system, monthly capitation codes that depend on visit counts, strict CMS documentation requirements, high-frequency patient encounters, and payer rules that shift every calendar year. When any one of those pieces falls out of alignment, claims are denied. Revenue disappears. And because dialysis patients come in multiple times per week, every uncorrected billing error repeats itself over and over before anyone traces it back to the source.

This guide is written for dialysis facilities, nephrology practices, and billing teams that want to understand exactly where the money goes and what it takes to stop losing it. We are going to walk through the most damaging dialysis billing pitfalls, explain why each one happens, what it costs, and what the fix looks like in practice. This is not a surface-level overview. This is what working inside dialysis billing actually reveals over time.

The ESRD Prospective Payment System, established by CMS under Section 1881(b)(14) of the Social Security Act, bundles nearly all renal dialysis services into a single per-treatment payment. Drugs, laboratory services, supplies, and capital costs for maintenance dialysis are all folded into one payment rather than billed as individual line items.

For 2026, CMS finalized the ESRD PPS base rate at $281.71, an increase of $7.89 from the 2025 rate, reflecting a 2.1 percent market basket update. CMS projects total payments across approximately 7,600 ESRD facilities to reach $6 billion this year.

The bundled model creates significant billing risk. When a separately billable service gets buried inside the bundle, the facility loses entitled revenue. When a bundled service gets billed as a separate line item, the claim triggers an overpayment alert. Knowing the boundary between bundled and separately billable is the foundation everything else is built on.

Starting January 1, 2025, oral-only drugs including phosphate binders moved into the ESRD PPS bundle. CMS established the TDAPA to reimburse these at 100 percent of average sales price, with an additional $36.41 per claim for dispensing and storage. Billing teams that have not updated their protocols are either missing the $36.41 payment or billing oral-only drugs outside the bundle in ways that create compliance exposure.

MCP codes run from CPT 90951 through 90970 and cover the nephrologist's monthly management of ESRD patients. The code selected depends on two variables: the patient's age and the number of face-to-face visits completed within the calendar month. This structure is where nephrology practices consistently lose revenue.

The most common MCP error is selecting the wrong code because nobody tracked how many qualifying visits actually occurred during the month. An adult patient who receives three or more face-to-face visits qualifies for 90960. An adult patient with two visits qualifies for 90961. An adult with one visit qualifies for 90966. If your billing team is coding based on what the schedule shows rather than what the documentation confirms happened, the codes are wrong. If visits were missed and no one caught it before the claim was submitted, you are billing for a level of service you cannot support.

The second most common MCP error involves concurrent billing violations. Medicare prohibits billing MCP codes during the same month that Chronic Care Management codes are billed for a dialysis patient. CCM and ESRD MCP are mutually exclusive. Similarly, when a dialysis patient is hospitalized, the MCP billing does not apply to the inpatient period. Only outpatient services qualify. Practices without a clear system for tracking hospitalization dates routinely submit MCP claims that overlap with inpatient stays, resulting in denials and recoupment requests.

CMS billing guidelines for ESRD are explicit. One claim per calendar month. Service dates for January go on a January claim. Service dates for February go on a February claim. Claims that cross from one calendar month into another are returned to the provider.

This rule seems obvious. But in a facility where patients receive dialysis three times per week and billing is processed in batches, it is surprisingly easy to submit a claim that includes a December 30th session and a January 2nd session on the same form. When that happens, the claim comes back. The facility resubmits. Time is lost. Cash flow suffers. And if this pattern repeats across dozens of patients, the aggregate impact on days in accounts receivable is significant.

The fix is a clean month-end billing cutoff protocol. Claims for each calendar month should be locked and prepared before new-month sessions begin appearing in the billing system. Most billing software can flag cross-month submissions before they go out the door. In practices where that configuration has not been done, the error keeps repeating.

A related rule: hemodialysis and peritoneal dialysis cannot appear on the same claim. If a patient transitions between modalities within a calendar month, two separate claims must be submitted. Facilities that miss this produce either denials or underpayments depending on how the payer processes the submission.

The V modifiers are non-negotiable in dialysis billing. The last dialysis session of the month on each claim must carry a V5, V6, or V7 modifier. V5 means the patient is under a care plan managed by the attending physician. V6 is for patients expected to improve or recover renal function. V7 indicates home dialysis. Without the correct V modifier on the last line of the claim, the claim fails CMS edit requirements and is returned.

G modifiers interact with V modifiers on HCPCS code 90999. When billing hemodialysis using 90999 with revenue code 082X, the G modifier must follow the V modifier in sequence. Reversing the order or omitting either modifier produces a claim error.

Modifier 59, used to flag a distinct procedural service, is frequently applied incorrectly when separately billable services are provided on the same date as a dialysis session. Using it without documentation supporting a separately identifiable service invites an audit. Not using it when documentation supports a separate service means that service gets bundled and goes unpaid.

Every dollar of dialysis revenue ultimately depends on what is in the chart. Documentation failures do not just cause individual claim denials. They create pattern-level vulnerabilities that payers target during audits.

The value code requirements for ESRD claims are detailed and non-negotiable. Height and weight must be reported for all ESRD patients using the appropriate value codes. Hemoglobin and hematocrit values should be included using occurrence code 51. At least one of the following condition codes must be present: 71, 72, 73, 74, 76, 80, or 59 for certain claim types. Facilities not capturing and transmitting these data elements are submitting technically deficient claims.

Starting January 1, 2025, CMS requires "time on machine" to be reported on each dialysis claim using value code D6. This is not a suggested field. EHR systems must be configured to capture treatment duration and transmit it correctly. Facilities that have not updated their EHR configuration are out of compliance with current CMS requirements and flagging themselves for claim review.

For home dialysis patients, the documentation burden is higher. Training sessions, supply orders, remote monitoring activity, and patient self-reports must be captured and reflected in the billing record. Home dialysis revenue is significant but it requires documentation infrastructure that in-center billing teams often have not built when transitioning patients to home modalities.

The ESRD bundle includes a defined set of services. But not everything a dialysis patient receives during treatment is included in that bundle. Some services remain separately billable. Facilities that do not know the boundary between bundled and separately billable services consistently leave revenue uncaptured.

Laboratory services ordered for non-ESRD conditions are not bundled into the ESRD PPS payment. If a dialysis patient receives lab work related to a comorbid condition separate from the ESRD diagnosis, that lab work can be billed outside the bundle. Facilities that route all lab charges through the dialysis claim without distinguishing between ESRD-related and non-ESRD-related labs are leaving separately billable revenue uncaptured.

Outlier payments represent another category of separate revenue that requires active management. CMS provides high-cost outlier payments when there are unusual variations in the type or amount of medically necessary care. The fixed dollar loss threshold for adult patients in 2026 has been adjusted to $14.80. Facilities must document the unusually high-cost services and track outlier eligibility by patient. The payer will not identify this automatically.

Most dialysis billing losses trace back to the front end of the revenue cycle, not the back end. Insurance eligibility errors, incorrect patient demographics, and missing authorization documentation create problems that compound across every subsequent claim for that patient.

ESRD coverage eligibility should be verified monthly, not just at intake. Coverage status changes. Medicare primary and secondary payer sequencing shifts when patients gain or lose employer-sponsored insurance. Medicaid spend-down thresholds affect coverage. A patient verified at admission may be in a completely different coverage situation six months later. If the billing team has not re-verified, every subsequent claim carries payer sequencing errors.

Prior authorization requirements for high-cost drugs, certain home dialysis equipment under the TPNIES framework, and imaging or specialty consultations vary by commercial payer. Facilities that submit these claims without confirmed authorizations receive preventable denials. The rework costs time, and not every appeal succeeds.

Dialysis billing done correctly is not something most general billing companies can deliver. The ESRD bundled payment rules, the MCP code family, the modifier sequencing requirements, and the 2026 regulatory updates all require specific expertise. Sirius Solutions Global brings that expertise to every dialysis and nephrology account we manage.

Our billing team reviews every claim against current CMS ESRD billing guidelines before submission. We track MCP visit counts by patient throughout the month so the correct capitation code is selected every time. We verify insurance eligibility monthly and flag MSP coordination period changes before they cause payer sequencing errors. We maintain value code and occurrence code compliance on every claim, and our workflows include the value code D6 time-on-machine requirement that took effect in 2025.

When claims are denied, we work them within 24 hours. We identify the root cause, correct the claim, and resubmit or appeal with supporting documentation. We report denial trends to our clients monthly so recurring problems get fixed at the process level, not just the claim level.

If your facility is experiencing any of the pitfalls in this guide, contact Sirius Solutions Global for a free dialysis billing assessment. We will show you exactly where the revenue is going and what it takes to recover it.

Comparing Dialysis Billing Service Providers in 2026

The differences above are not cosmetic. In dialysis billing, a general billing service that does not know the MCP code family, the V modifier sequencing rules, or the monthly claim cutoff requirements will make the same errors month after month. The cost of those errors compounds across every patient in the facility.

The finalized 2026 ESRD PPS base rate of $281.71 means every facility needs to verify their billing system fee schedules reflect the new rate. Underpayments from outdated schedules are not automatically corrected by payers. Facilities that do not update their systems receive less than they are owed and often miss the discrepancy entirely until a billing audit.

The termination of the ESRD Treatment Choices Model effective December 31, 2025 removes payment adjustments that some facilities were counting on. Billing teams that factored ETC model adjustments into revenue projections need to update their forecasting for 2026.

The updated outlier policy with the lowered adult FDL threshold of $14.80 changes which cases qualify for outlier payment. Facilities that were previously eligible in certain high-cost cases may no longer qualify. Understanding this matters for both revenue forecasting and documentation decisions around unusual care variation claims.

Dialysis billing does not forgive errors quietly. The bundled payment structure, the monthly capitation model, the modifier requirements, and the documentation mandates all create an environment where small mistakes cost large amounts across high-frequency patient encounters.

The facilities that protect revenue in this environment share one quality. They treat dialysis billing as a specialty function that requires specific knowledge. They do not assume a general billing team can figure it out on the job.

If your facility has been struggling with denial rates, MCP undercoding, cross-month claim errors, or any of the pitfalls covered in this guide, the answer is not to work harder on the same process. The answer is to bring in people who know dialysis billing from the inside.

Free Demo